| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Volume 272, Number 48, Issue of November 28, 1997 pp. 29995-29997
(Received for publication, August 27, 1997, and in revised form, October 7, 1997)
,,,
From 
Hematologic Malignancy and § Cancer
Pharmacology, Department of Adult Oncology, Dana Farber Cancer
Institute, Harvard Medical School, Boston, Massachusetts 02115 and
¶ Northwestern University Medical School, Robert H. Lurie Cancer
Center, Chicago, Illinois 60611
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
FOOTNOTES
REFERENCES
ABSTRACT 
Cytochrome c is a mitochondrial protein that induces apoptosis when accumulated in the cytosol in response to diverse stress inducers. This protein has also been shown to cause apoptosis when added to cell free extracts. In this report, we studied the role of cytochrome c (cyto-c) in dexamethasone (Dex), anti-Fas monoclonal antibody (mAb), and ionizing radiation-induced apoptosis in multiple myeloma cells. The results demonstrate that ionizing radiation-induced apoptosis is associated with an increase in cytosolic cyto-c levels, whereas apoptosis induced by Dex or anti-Fas mAb has no detectable effect on cyto-c release. By contrast, caspase-3 was activated in response to all of these agents. Thus, our findings suggest that Dex or anti-Fas mAb-induced apoptosis is not accompanied by cyto-c release and that there are at least two different pathways leading to activation of caspases and induction of apoptosis in multiple myeloma cells that can be distinguished by accumulation of cytosolic cyto-c.
INTRODUCTION
The cellular response to diverse classes of stress inducers
includes growth arrest and activation of apoptosis; however, the intracellular signals that control these events are unclear. Apoptosis is triggered through a controlled program that is associated with distinctive morphological changes including membrane blebbing, cytoplasmic and nuclear condensation, chromatin aggregation, and formation of apoptotic bodies (1). The induction of apoptosis by
various stimuli is associated with activation of cysteine proteases (caspases) (2) and cleavage of poly(ADP-ribose) polymerase (3, 4),
DNA-dependent protein kinase (5), protein kinase C 
(PKC-)1 (6), and other
substrates. Activation of caspases (CPP32, interleukin 1-
converting
enzyme, interleukin 1- converting enzyme homologue-1, and mammalian
ced-3 homologue-2) and DNA fragmentation are two well
characterized biochemical markers of apoptosis. Direct evidence for
involvement of caspases in apoptosis is derived from studies with the
baculovirus protein p35, which directly inhibits cysteine proteases and
blocks activation of apoptosis (7, 8). Genetic and biochemical evidence
has indicated that apoptosis proceeds by one or more ordered pathways.
Studies with Caenorhabditis elegans in particular have
demonstrated that ced-3 is necessary for cell death (9-11).
Mammalian homologues of ced-3 include the family of caspases
(2).
Recent studies have shown that mitochondria may play an important role in inducing apoptosis by releasing cyto-c (12-14). The addition of exogenous cyto-c to cytosolic preparations from growing cells activates caspases and also induces DNA fragmentation in isolated nuclei (12). Furthermore, it was shown recently that DNA fragmentation factor is also required to mediate apoptosis after activation of caspase 3 (CPP32) (15).
To determine the role of cyto-c in induction of apoptosis, we examined the effect of three distinct stress inducers, IR, Dex, and anti-Fas mAb, in MM.1S multiple myeloma (MM) cell line and patient MM cells. We and others have previously demonstrated that IR, Dex, and Fas trigger apoptosis in MM cells (16-19). The results of the present study demonstrate that IR, but not Dex and anti-Fas mAb, induces accumulation of cytosolic cyto-c; all of these agents caused apoptosis in these cells. Similar results were obtained when cells from MM patient were treated with these agents. Taken together, the results of the present study indicate that in MM cells, there are at least two different pathways that lead to apoptosis in MM cells: one correlated and the other not correlated with release of cyto-c from mitochondria.
MATERIALS AND METHODS
Human MM.1S multiple myeloma
cells were grown in RPMI 1640 medium supplemented with 10%
heat-inactivated fetal bovine serum, 100 units/ml penicillin, 100 µg/ml streptomycin, and 2 mM L-glutamine (20,
21). Mononuclear cells were isolated from a patient with MM (patient
PCL) by Ficoll-Hypaque density gradient centrifugation and incubated
with HB-7 (anti-CD38) mAb-biotin-streptavidin and 2H4 (anti-CD45RA)
mAb-fluorescein isothiocyanate on ice. Tumor cells (96 ± 2%
CD38+45RA
) were isolated using an Epics C cell sorter (Coulter
Electronics, Hialeah, FL), washed, and resuspended in RPMI 1640 medium
containing 10% fetal bovine serum and antibiotics. 
-Irradiation was
performed at room temperature using a Gamma-cell 1000 (Atomic Energy of
Canada, Ottawa, Canada) under aerobic conditions, with a
137Cs source emitting at a fixed dose rate of 0.76 Gy
min
1 as determined by dosimetry. Cells were also treated
with 10 µM dexamethasone (Sigma) or with 7C11 anti-Fas
monoclonal antibody as described previously (16).
1 × 106 cells were washed twice with cold PBS and fixed by the addition of 40% cold ethanol at 4 °C for 30 min. Cells were then washed with PBS and treated with RNase (50 µg/ml) for 45 min at 37 °C. After treatment with RNase, cells were washed with PBS and resuspended in PBS containing 15 µg/ml propidium iodide. Flow cytometric analyses was done using FACScan.
Preparation of S-100 Cytosolic Fractions from MM.1S and MM Patient CellsMM.1S or patient MM cells were washed twice with PBS, and the pellet was suspended in 5 ml of ice-cold buffer A (20 mM HEPES, pH 7.5, 1.5 mM MgCl2, 10 mM KCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, 10 µg/ml leupeptin, and aprotinin and pepstatin A) containing 250 nM sucrose. The cells were homogenized three times in a Dounce homogenizer with a sandpaper-polished pestle. Cytosolic fractions were isolated as described previously (22).
Antibodies and Western Blot AnalysisProteins were
separated from cell lysates by SDS-PAGE, transferred to nitrocellulose,
and probed with anti-cyto-c (23), anti-CPP32 (Transduction
Laboratories), / anti-PKC- (Santa Cruz), anti-Tubulin (Sigma), or
anti-HSP 60 (Stressgen, Canada) antibodies. The blots were developed by
enhanced chemiluminescence (Amersham) using the manufacturer's
protocol.
S-100 cytosolic fractions from untreated MM.1S cells were incubated with anti-cyto-c antibodies and protein A-Sepharose for 2 h at 4 °C, and the beads were pelleted by centrifugation. This immunodepletion procedure was repeated twice in the resulting supernatant. The absence of cyto-c in immunodepleted extracts (cyto-c free lysates) was confirmed by Western blotting.
In Vitro Assay for Cyto-c-dependent Cleavage of PKC-
Concentrated 10 µl of cyto-c free lysate was
incubated with purified cyto-c (Sigma) for 2 h at room
temperature in 40 µl of buffer A, followed by the addition of 6 × SDS sample buffer. After boiling for 5 min, samples were subjected
to 10% SDS-PAGE, and the proteins were transferred to nitrocellulose.
The filters were probed with anti-PKC- antibodies.
RESULTS AND DISCUSSION
To determine induction of apoptosis in MM.1S MM cells by diverse
inducers, the cells were treated with 20 Gy of IR, 10 µM Dex, or 5 µg/ml of anti-Fas mAb for 48 h and flow cytometric
analyses using propidium iodide was performed (16, 17). Treatment of cells with IR results in 71 ± 2% (n = 3)
apoptotic cells, whereas Dex and anti-Fas mAb treatment leads to
61 ± 1.6 and 66 ± 3% apoptotic cells (n = 3), respectively. Previous studies have shown that accumulation of
cyto-c in the cytosol occurs in response to multiple apoptotic stimuli and plays an important role in inducing apoptosis (12-14). To examine whether the release of cyto-c from
mitochondria is a universal event during apoptosis, MM.1S MM cells were
exposed to IR, Dex, or anti-Fas mAb antibody, and their effects on
accumulation of cyto-c in cytosol were analyzed. The
cytosolic S-100 fractions were isolated and analyzed for levels of
cyto-c. Cytosolic cyto-c levels were increased at
3 and 6 h after irradiation (Fig.
1A). In contrast to IR,
cyto-c levels in the cytosol were unchanged during treatment
of MM.1S cells with either Dex or anti-Fas mAb (Fig. 1B and
2A). The IR-induced increase
in cytosolic cyto-c was specific, because there was no
change in the protein levels of tubulin (Fig. 1B,
lower panel). Similar results were obtained when patient MM
(PCL) cells were exposed to IR, Dex, or anti-Fas mAb (Fig.
2B, right and left upper panels, and
data not shown). The treatment of PCL patient MM cells did not affect
the protein levels, as evidenced by the unaltered tubulin protein
levels (Fig. 2B, right and left lower
panels). As an additional control, the blots were reprobed with a
specific mitochondrial protein, HSP-60. The results demonstrate
undetectable levels of HSP-60 in the S-100 cytosolic fractions (data
not shown). These results indicate that the release of
cyto-c from mitochondria may be important for triggering apoptosis in response to certain agents, in particular, DNA damaging agents, and that this is not an obligatory event during Dex or anti-Fas
mAb-induced apoptosis in MM cells.
[View Larger Version of this Image (27K GIF file)]
[View Larger Version of this Image (31K GIF file)]
Multiple lines of evidence indicate that apoptosis can be triggered by
the activation of cysteine proteases, and the most intensively studied
apoptotic caspase is CPP32 (caspase-3) (24). Furthermore, it was
recently shown in a cell free system that the addition of purified
cyto-c to the cyto-c-depleted extracts activates
CPP32 and DNA fragmentation (15). Because treatment of MM.1S MM cells
with either Dex or anti-Fas mAb activates DNA fragmentation in the
absence of cytosolic accumulation of cyto-c, we asked
whether CPP32 is cleaved and activated by these inducers. MM.1S MM
cells were treated with Dex or anti-Fas mAb, and the lysates were
subjected to immunoblotting either with CPP32 or its known substrate
protein kinase C (6). The results demonstrate cleavage and
activation of CPP32 (as shown by cleavage of PKC-) in response to
Dex or anti-Fas mAb (Fig. 3, A
and B). Similar results were obtained when MM.1S cells were
treated with IR (Fig. 3, A and B). Moreover, in
an in vitro cell free system, the addition of purified
cyto-c to the cyto-c immunodepleted MM.1S
cytosolic lysates (Fig. 3C, left panel) showed
cleavage of PKC- and CPP32 (Fig. 3C, right
panel and data not shown). The results further suggest that
MM.1S cytosolic fractions trigger the apoptotic program when
cyto-c was added exogeneously. Taken together, the results strongly suggest that cleavage and activation of CPP32 and induction of
apoptosis by anti-Fas mAb and Dex in MM.1S cells is not accompanied by
the accumulation of cyto-c in the cytosol.
in response to
IR, Dex, and anti-Fas mAb. MM.1S cells were treated with IR, Dex,
or anti-Fas mAb and harvested at the indicated times. Total cell
lysates were analyzed by immunoblotting with anti-CPP32 (A)
or anti-PKC- (B) antibodies. U-937 cells treated with IR
were used as a positive control for cleavage of PKC-. C,
cytosolic proteins obtained from untreated MM.1S cells were subjected
to three rounds of immunodepletion with anti-cyto-c
antibody. Depletion of cyto-c was confirmed by immunoblotting with anti-cyto-c antibody (left
panel). In vitro PKC- cleavage assay was performed
by adding different doses of purified cyto-c to the
cyto-c depleted extracts (first lane, right panel) as described under "Materials and Methods." Lysates
from IR-treated U-937 cells were used as a positive control for PKC- cleavage. FL, full length; CF, cleaved fragment;
IB, immunoblotting.
[View Larger Version of this Image (36K GIF file)]
The results described above indicate that there are multiple pathways that can trigger the program that leads to apoptosis. The multiplicity and complexity of apoptotic signals do not suggest the same linear pathway. Release of cyto-c from mitochondria to cytosol has been shown to be a potential target for regulation of apoptosis (13, 14, 22). Our results clearly demonstrate that accumulation of cyto-c in cytosol, which is associated with IR-induced apoptosis, is not observed during either Dex- or Fas-induced apoptosis in MM cells. Further studies are needed to elucidate the mechanisms involved in cyto-c-dependent and -independent induction of apoptosis in MM cells.
FOOTNOTES
, protein
kinase C ; IR, ionozing radiation; cyto-c, cytochrome
c; MM, multiple myeloma; Dex, dexamethasone; mAb,
monoclonal antibody; PBS, phosphate-buffered saline; PAGE,
polyacrylamide gel electrophoresis; Gy, gray; CPP32, cysteine protease
protein with a molecular mass of 32 kDa.
REFERENCES
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Suvannasankha, C. D. Crean, R. Shanmugam, S. S. Farag, R. Abonour, H. S. Boswell, and H. Nakshatri Antimyeloma Effects of a Sesquiterpene Lactone Parthenolide Clin. Cancer Res., March 15, 2008; 14(6): 1814 - 1822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Podar, M. S. Raab, J. Zhang, D. McMillin, I. Breitkreutz, Y.-T. Tai, B. K. Lin, N. Munshi, T. Hideshima, D. Chauhan, et al. Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl) Blood, February 15, 2007; 109(4): 1669 - 1677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chauhan, P. Neri, M. Velankar, K. Podar, T. Hideshima, M. Fulciniti, P. Tassone, N. Raje, C. Mitsiades, N. Mitsiades, et al. Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM) Blood, February 1, 2007; 109(3): 1220 - 1227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chauhan, G. Li, K. Podar, T. Hideshima, P. Neri, D. He, N. Mitsiades, P. Richardson, Y. Chang, J. Schindler, et al. A Novel Carbohydrate-Based Therapeutic GCS-100 Overcomes Bortezomib Resistance and Enhances Dexamethasone-Induced Apoptosis in Multiple Myeloma Cells Cancer Res., September 15, 2005; 65(18): 8350 - 8358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakazato, K. Ito, Y. Ikeda, and M. Kizaki Green Tea Component, Catechin, Induces Apoptosis of Human Malignant B Cells via Production of Reactive Oxygen Species Clin. Cancer Res., August 15, 2005; 11(16): 6040 - 6049. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hamasaki, T. Hideshima, P. Tassone, P. Neri, K. Ishitsuka, H. Yasui, N. Shiraishi, N. Raje, S. Kumar, D. H. Picker, et al. Azaspirane (N-N-diethyl-8,8-dipropyl-2-azaspiro [4.5] decane-2-propanamine) inhibits human multiple myeloma cell growth in the bone marrow milieu in vitro and in vivo Blood, June 1, 2005; 105(11): 4470 - 4476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-I PENG, C.-J. CHANG, M.-J. GUO, Y.-H. WANG, J.-S. YU, H.-Y. WU, and M.-J. JOU Mitochondrion-Targeted Photosensitizer Enhances the Photodynamic Effect-Induced Mitochondrial Dysfunction and Apoptosis Ann. N.Y. Acad. Sci., May 1, 2005; 1042(1): 419 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Raje, S. Kumar, T. Hideshima, K. Ishitsuka, D. Chauhan, C. Mitsiades, K. Podar, S. Le Gouill, P. Richardson, N. C. Munshi, et al. Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma Blood, December 15, 2004; 104(13): 4188 - 4193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chauhan, G. Li, K. Podar, T. Hideshima, C. Mitsiades, R. Schlossman, N. Munshi, P. Richardson, F. E. Cotter, and K. C. Anderson Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells Blood, October 15, 2004; 104(8): 2458 - 2466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hideshima, P. L. Bergsagel, W. M. Kuehl, and K. C. Anderson Advances in biology of multiple myeloma: clinical applications Blood, August 1, 2004; 104(3): 607 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chauhan, G. Li, K. Podar, T. Hideshima, R. Shringarpure, L. Catley, C. Mitsiades, N. Munshi, Y. T. Tai, N. Suh, et al. The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti-multiple myeloma (MM) activity and overcome bortezomib resistance Blood, April 15, 2004; 103(8): 3158 - 3166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-E. Kim and S. R. Tannenbaum S-Nitrosation Regulates the Activation of Endogenous Procaspase-9 in HT-29 Human Colon Carcinoma Cells J. Biol. Chem., March 12, 2004; 279(11): 9758 - 9764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Evens, S. Prachand, B. Shi, M. Paniaqua, L. I. Gordon, and R. B. Gartenhaus Imexon-Induced Apoptosis in Multiple Myeloma Tumor Cells Is Caspase-8 Dependent Clin. Cancer Res., February 15, 2004; 10(4): 1481 - 1491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Hoijman, L. Rocha Viegas, M. I. Keller Sarmiento, R. E. Rosenstein, and A. Pecci Involvement of Bax Protein in the Prevention of Glucocorticoid-Induced Thymocytes Apoptosis by Melatonin Endocrinology, January 1, 2004; 145(1): 418 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hideshima, D. Chauhan, T. Hayashi, K. Podar, M. Akiyama, C. Mitsiades, N. MItsiades, B. Gong, L. Bonham, P. de Vries, et al. Antitumor Activity of Lysophosphatidic Acid Acyltransferase-{beta} Inhibitors, a Novel Class of Agents, in Multiple Myeloma Cancer Res., December 1, 2003; 63(23): 8428 - 8436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chauhan, G. Li, T. Hideshima, K. Podar, C. Mitsiades, N. Mitsiades, L. Catley, Y. T. Tai, T. Hayashi, R. Shringarpure, et al. Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistance Blood, November 1, 2003; 102(9): 3379 - 3386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chauhan, G. Li, R. Shringarpure, K. Podar, Y. Ohtake, T. Hideshima, and K. C. Anderson Blockade of Hsp27 Overcomes Bortezomib/Proteasome Inhibitor PS-341 Resistance in Lymphoma Cells Cancer Res., October 1, 2003; 63(19): 6174 - 6177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Marchetti, B. Di Marco, G. Cifone, G. Migliorati, and C. Riccardi Dexamethasone-induced apoptosis of thymocytes: role of glucocorticoid receptor-associated Src kinase and caspase-8 activation Blood, January 15, 2003; 101(2): 585 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Chauhan, L. Catley, T. Hideshima, G. Li, R. Leblanc, D. Gupta, M. Sattler, P. Richardson, R. L. Schlossman, K. Podar, et al. 2-Methoxyestradiol overcomes drug resistance in multiple myeloma cells Blood, August 28, 2002; 100(6): 2187 - 2194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hayashi, T. Hideshima, M. Akiyama, P. Richardson, R. L. Schlossman, D. Chauhan, N. C. Munshi, S. Waxman, and K. C. Anderson Arsenic Trioxide Inhibits Growth of Human Multiple Myeloma Cells in the Bone Marrow Microenvironment Mol. Cancer Ther., August 1, 2002; 1(10): 851 - 860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sasson and A. Amsterdam Stimulation of Apoptosis in Human Granulosa Cells from in Vitro Fertilization Patients and Its Prevention by Dexamethasone: Involvement of Cell Contact and Bcl-2 Expression J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3441 - 3451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Greenstein, K. Ghias, N. L. Krett, and S. T. Rosen Mechanisms of Glucocorticoid-mediated Apoptosis in Hematological Malignancies Clin. Cancer Res., June 1, 2002; 8(6): 1681 - 1694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Anderson, J. D. Shaughnessy Jr., B. Barlogie, J.-L. Harousseau, and G. D. Roodman Multiple Myeloma Hematology, January 1, 2002; 2002(1): 214 - 240. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. M. Luetjens, D. Kogel, C. Reimertz, H. Du{beta}mann, A. Renz, K. Schulze-Osthoff, A.-L. Nieminen, M. Poppe, and J. H. M. Prehn Multiple Kinetics of Mitochondrial Cytochrome c Release in Drug-Induced Apoptosis Mol. Pharmacol., November 1, 2001; 60(5): 1008 - 1019. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Soeda, S. Miyagawa, K. Sano, J. Masumoto, S.'I. Taniguchi, and S. Kawasaki Cytochrome c release into cytosol with subsequent caspase activation during warm ischemia in rat liver Am J Physiol Gastrointest Liver Physiol, October 1, 2001; 281(4): G1115 - G1123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Chen, B. Gong, A. S. Mahmoud-Ahmed, A. Zhou, E. D. Hsi, M. Hussein, and A. Almasan Apo2L/TRAIL and Bcl-2-related proteins regulate type I interferon-induced apoptosis in multiple myeloma Blood, October 1, 2001; 98(7): 2183 - 2192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Dai, C. Yu, V. Singh, L. Tang, Z. Wang, R. McInistry, P. Dent, and S. Grant Pharmacological Inhibitors of the Mitogen-activated Protein Kinase (MAPK) Kinase/MAPK Cascade Interact Synergistically with UCN-01 to Induce Mitochondrial Dysfunction and Apoptosis in Human Leukemia Cells Cancer Res., July 1, 2001; 61(13): 5106 - 5115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hishita, S. Tada-Oikawa, K. Tohyama, Y. Miura, T. Nishihara, Y. Tohyama, Y. Yoshida, T. Uchiyama, and S. Kawanishi Caspase-3 Activation by Lysosomal Enzymes in Cytochrome c-independent Apoptosis in Myelodysplastic Syndrome-derived Cell Line P39 Cancer Res., April 1, 2001; 61(7): 2878 - 2884. [Abstract] [Full Text]
|
|
|
|
|
|
T. Hideshima, P. Richardson, D. Chauhan, V. J. Palombella, P. J. Elliott, J. Adams, and K. C. Anderson The Proteasome Inhibitor PS-341 Inhibits Growth, Induces Apoptosis, and Overcomes Drug Resistance in Human Multiple Myeloma Cells Cancer Res., April 1, 2001; 61(7): 3071 - 3076. [Abstract] [Full Text]
|
|
|
|
|
|
W. S. Dalton, P. L. Bergsagel, W. M. Kuehl, K. C. Anderson, and J. L. Harousseau Multiple Myeloma Hematology, January 1, 2001; 2001(1): 157 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hideshima, D. Chauhan, Y. Shima, N. Raje, F. E. Davies, Y.-T. Tai, S. P. Treon, B. Lin, R. L. Schlossman, P. Richardson, et al. Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy Blood, November 1, 2000; 96(9): 2943 - 2950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kawamura, M. Kizaki, K. Yamato, H. Uchida, Y. Fukuchi, Y. Hattori, T. Koseki, T. Nishihara, and Y. Ikeda Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3 Blood, September 15, 2000; 96(6): 2005 - 2011. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ito, P. Pandey, A. Place, M. B. Sporn, G. W. Gribble, T. Honda, S. Kharbanda, and D. Kufe The Novel Triterpenoid 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic Acid Induces Apoptosis of Human Myeloid Leukemia Cells by a Caspase-8-dependent Mechanism Cell Growth Differ., May 1, 2000; 11(5): 261 - 267. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Jouvet, P. Rustin, D. L. Taylor, J. M. Pocock, U. Felderhoff-Mueser, N. D. Mazarakis, C. Sarraf, U. Joashi, M. Kozma, K. Greenwood, et al. Branched Chain Amino Acids Induce Apoptosis in Neural Cells without Mitochondrial Membrane Depolarization or Cytochrome c Release: Implications for Neurological Impairment Associated with Maple Syrup Urine Disease Mol. Biol. Cell, May 1, 2000; 11(5): 1919 - 1932. [Abstract] [Full Text]
|
|
|
|
|
|
L. He, A. T. Poblenz, C. J. Medrano, and D. A. Fox Lead and Calcium Produce Rod Photoreceptor Cell Apoptosis by Opening the Mitochondrial Permeability Transition Pore J. Biol. Chem., April 14, 2000; 275(16): 12175 - 12184. [Abstract] [Full Text] [PDF]
|
|
